Basic Anafranil Information

• INN (International Nonproprietary Name): Clomipramine.
• Brand Names Available In United States: Anafranil (capsules: 25 mg, 50 mg, 75 mg; blister & bottle).
• ATC Code: N06AA04.
• Forms & Dosages: Capsules and tablets are sold in 10 mg (varies), 25 mg, 50 mg, and 75 mg strengths for oral administration.
• Manufacturers In United States: Major originator Novartis Pharma AG (via Sandoz) and other global suppliers include Sun Pharma, Teva, Sanofi and generic manufacturers; local availability may vary by pharmacy.
• Registration Status In United States: Prescription-only (Rx); FDA-approved for obsessive-compulsive disorder in adults and pediatric patients aged 10 years and older.
• OTC / Rx Classification: Prescription-only medication (Rx).

Everyday Use & Best Practices

Many people new to Anafranil ask whether to take it in the morning or at night.

A common practical rule is to start clomipramine at bedtime to reduce daytime drowsiness and orthostatic symptoms.

For obsessive-compulsive disorder, initial bedtime dosing of 25 mg with gradual increases is the usual approach.

Typical maintenance doses for OCD often fall between 100–250 mg per day given in divided doses, with a maximum of 250 mg per day.

If daytime sedation occurs, consider moving the larger portion of the dose to bedtime.

If new or worsening insomnia appears, take the medication earlier in the day after discussing with your prescriber.

Morning Vs Evening Dosing

Start low at night to see how drowsy clomipramine makes you before shifting dose timing.

Patients often begin with 25 mg at bedtime and titrate up in ~25 mg steps as tolerated.

Maintenance dosing commonly ends up split into morning and evening doses for better tolerability and steady blood levels.

Taking With Or Without Meals

Anafranil can be taken with or without food.

Taking it with a light snack often reduces nausea and stomach upset during initiation.

Keep dosing times consistent day to day to maintain steady blood levels.

• Checklist For Titration:
• Week 1: 25 mg at bedtime; note daytime drowsiness and dizziness.
• Week 2: Increase by 25 mg every 3–7 days as tolerated toward target range.
• Weeks 3–4: Reassess benefit and side effects; aim for lowest effective maintenance dose.

Use a simple pillbox routine and a printed daily medication log to track each dose change, missed doses, and side effects.

Keeping a medication checklist helps when you need to report progress to your prescriber or pharmacist.

Safety Priorities

Patients often want to know whether Anafranil is safe for them.

Certain conditions make clomipramine unsuitable or require specialist supervision.

Who Should Avoid It

• Absolute Contraindications: recent myocardial infarction, known hypersensitivity to clomipramine or other tricyclics, concurrent use of monoamine oxidase (MAO) inhibitors, and severe liver disease.
• People with significant cardiac conduction problems or uncontrolled arrhythmias should avoid clomipramine unless monitored closely.
• Patients with a history of seizures require specialist assessment before starting due to seizure risk.
• Uncontrolled narrow-angle glaucoma and severe prostatic hypertrophy are relative contraindications because of anticholinergic effects.
• In older adults, begin at a very low dose and monitor cardiac status and anticholinergic side effects.

Activities To Limit

Until you know how Anafranil affects you, avoid driving, operating heavy machinery, or making high-stakes decisions.

Drowsiness, dizziness, or blurred vision are common during initiation and dose increases.

Avoid or limit alcohol because it increases sedation and the risk of orthostatic hypotension.

• Printable What To Avoid Checklist:
• Avoid alcohol while adjusting dose.
• Do not combine with MAO inhibitors.
• Delay driving or heavy machinery until you know your response.
• Report fainting, palpitations, or sudden vision changes immediately.

Keep an emergency plan that lists contraindicated medications, emergency contacts, and your prescriber’s phone number.

Dosage & Adjustments

People commonly ask how fast clomipramine should be increased and what target ranges look like.

Follow slow titration and aim for the lowest effective dose that controls symptoms.

General Regimen

Typical adult initiation for OCD is 25 mg at bedtime with increases of roughly 25 mg as tolerated.

Many adults stabilize between 100–250 mg daily given in divided doses, with a maximum of 250 mg per day.

For depression or off-label uses, doses are individualized and often lower than the upper OCD range.

Titrate slowly over 2–3 weeks during the acute phase, then seek the lowest effective maintenance dose.

Special Cases

Children and adolescents with OCD usually start at 25 mg and titrate toward approximately 3 mg/kg/day when indicated.

Maximum pediatric dosing in younger adolescents is about 200 mg per day or roughly 3 mg/kg/day, whichever limit applies.

Elderly patients should begin at a very low dose and increase slowly with cardiac monitoring.

For patients with liver or kidney impairment, no formal dose adjustment is defined; use caution and monitor clinically.

If you miss a dose, take it as soon as remembered unless it is close to the next scheduled dose; do not double doses.

User Testimonials

Patients often ask what others experience on Anafranil before deciding to start.

Real-world reports show both strong benefits and common tolerability challenges.

Positive Reports

Many patients report meaningful reduction in obsessive-compulsive symptoms when SSRIs fail.

Some describe clearer thinking and significantly less time spent on rituals after adequate titration to therapeutic doses.

Patients using brand Anafranil note predictable capsule strengths such as 25 mg, 50 mg, and 75 mg.

Common Challenges

Frequent patient-reported challenges include initial drowsiness, dry mouth, constipation, weight gain, and orthostatic lightheadedness.

Older adults often struggle with urinary retention or blurred vision due to the drug’s anticholinergic burden.

Slow titration is commonly advised by clinicians to reduce oversedation and other early side effects.

• Reported Benefits vs Challenges
• Benefits: robust effect for treatment-resistant OCD, clearer daily functioning, predictable capsule strengths.
• Challenges: drowsiness, dry mouth, constipation, orthostatic hypotension, weight gain.

Keep a symptom diary and share it with your prescriber to guide dose adjustments and supportive measures.

Printable Symptom Diary Template:

• Date | Time | Dose Taken | Side Effects Noted | Severity (1–10) | Notes for Prescriber

Buying Guide

People often ask where to buy Anafranil and whether to choose brand or generic clomipramine.

Anafranil is prescription-only in the U.S. but is available through multiple pharmacy channels.

Pharmacy Sources

Fill prescriptions at retail community pharmacies, hospital pharmacies, or legitimate online/mail-order pharmacies that require a valid U.S. prescription.

Ask your pharmacist about brand (Anafranil) versus generic clomipramine; generics from reputable manufacturers are usually less expensive and equally effective.

In our online pharmacy, anafranil is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

Costs vary by insurance, manufacturer, dosage, and whether you use a brand or generic product.

Brand-name Anafranil is generally costlier than generics made by Sun Pharma, Teva, Sandoz, or others.

Compare pharmacy discount programs, manufacturer coupons, and legitimate online pharmacies when price shopping.

Consider 90-day fills for stable maintenance dosing to reduce per-dose cost when permitted by your insurer.

What’s Inside & How It Works

Understanding active ingredients and mechanism helps set expectations for benefit and side effects.

Ingredients Overview

The active ingredient is clomipramine hydrochloride, a tricyclic antidepressant with notable anticholinergic activity.

Common capsule strengths include 25 mg, 50 mg, and 75 mg depending on packaging and region.

Inactive ingredients vary by manufacturer, so check product packaging if you have allergies or sensitivities.

Major manufacturers include Novartis/Sandoz, Sun Pharma, Teva, and others listed by regional suppliers.

Mechanism Basics

Clomipramine blocks reuptake of serotonin and norepinephrine and carries anticholinergic and antihistamine effects.

Its strong serotonin reuptake inhibition is why it is particularly effective for obsessive-compulsive disorder.

The ATC classification is N06AA04 indicating a tricyclic antidepressant (clomipramine).

Expect mood and compulsivity benefits to develop over weeks, while anticholinergic side effects can appear quickly after starting or increasing dose.

Main Indications

Patients want to know for which conditions Anafranil is approved and when it is used off-label.

Approved Uses

• Anafranil (clomipramine) is FDA-approved in the U.S. for the treatment of obsessive-compulsive disorder in adults and pediatric patients aged 10 years and older.
• Some countries additionally list indications for depressive syndromes; approvals vary by region.

Off-Label Uses

• Clinicians sometimes use clomipramine off-label for treatment-resistant depression, panic disorder, or other anxiety disorders when SSRIs have failed.
• Guidelines often place clomipramine as a second-line or adjunct option for refractory OCD due to efficacy combined with a higher side-effect burden than SSRIs.

Interaction Warnings

Interactions are a major safety concern with clomipramine.

Always provide your prescriber and pharmacist a complete medication list including OTCs and supplements.

Food Interactions

There are no major food restrictions listed, but avoid alcohol because it increases sedation and orthostatic hypotension risk.

Grapefruit is not widely listed as a direct contraindication, but metabolic interactions can vary by formulation and manufacturer, so check with your pharmacist.

Drug Conflicts

Major risks include concurrent MAO inhibitors, which can cause life-threatening serotonin syndrome.

Anafranil should not be combined with other strong serotonergic agents or certain antipsychotics without specialist oversight.

Be cautious with other QT-prolonging drugs and additional anticholinergic medications because of additive effects.

• Do Not Combine Checklist
• MAO inhibitors (absolute contraindication).
• Other strong serotonergic drugs without prescriber instruction.
• Medications that prolong QT interval unless carefully monitored.
• Other anticholinergics that increase urinary retention or vision problems.

Latest Evidence & Insights

Clinicians and patients want the current perspective on where clomipramine fits in therapy.

Recent trial summaries confirm clomipramine’s strong efficacy for OCD, especially after SSRI failure.

Recent Trial Takeaways

• Clomipramine is highly effective for OCD and can outperform some SSRIs in treatment-resistant cases.
• Comparative studies show higher rates of anticholinergic and cardiovascular side effects for clomipramine versus SSRIs.
• Use trial evidence to balance potential benefit against tolerability in shared decision-making.

Practical Clinical Insights

Best outcomes often follow slow titration and combination with behavioral therapy such as exposure and response prevention (ERP).

Baseline cardiac screening (ECG) is advised for older patients or those with cardiac risk factors.

Pharmacovigilance focuses on anticholinergic burden, weight gain, and orthostatic hypotension monitoring.

• Clinician Baseline Workup Checklist:
• Medication review for serotonergic or QT-risk drugs.
• Baseline ECG for patients with cardiac history or elderly patients.
• Assess liver/renal function if clinically indicated.

Alternative Choices

Patients commonly ask how Anafranil compares to SSRIs and other strategies.

Choice depends on efficacy needs, side-effect tolerability, and comorbid conditions.

SSRIs Vs Anafranil

Many guidelines recommend SSRIs such as sertraline, fluoxetine, or paroxetine as first-line treatments for OCD.

SSRIs generally have lower anticholinergic and cardiotoxic risk compared with clomipramine.

Anafranil can be more effective in SSRI-resistant cases due to stronger serotonin reuptake inhibition, but it carries more side effects.

When To Consider Other TCAs Or Augmentation

Other TCAs like imipramine or augmentation with antipsychotics and continued CBT/ERP may be options for partial responders.

If anticholinergic burden is a major concern, prioritize SSRIs or non-anticholinergic treatments first.

Regulation Snapshot

Regulatory status affects access, packaging, and storage recommendations.

Clomipramine and Anafranil are prescription-only in most regions with similar approved uses.

FDA / EMA Status

In the United States, Anafranil is prescription-only and FDA-approved for OCD in adults and children aged 10 years and older.

EMA and national regulators typically list clomipramine as prescription-only, often with approvals focused on OCD and sometimes certain depressive syndromes.

Prescription And Dispensing Notes

Always obtain a valid prescription and keep medications in original packaging when possible.

Common capsule strengths in the U.S., UK, and Canada include 25 mg, 50 mg, and 75 mg in blister packs or bottles.

Store at 20–25°C (68–77°F) and protect from light and moisture during transport and storage.

FAQ Section

Short answers to common patient questions can help manage expectations and safety.

Common Patient Questions

Quick Answers To Safety Concerns

• If you miss a dose, take it when remembered unless it is close to your next dose; do not double up.
• Overdose requires emergency care; watch for cardiac arrhythmias and severe anticholinergic effects.
• If pregnant or breastfeeding, discuss risks versus benefits with your prescriber before starting or continuing treatment.

Ask your prescriber about ECG screening, other medications that increase serotonin, and any history of cardiac disease before starting therapy.

Guidelines For Proper Use

Clear steps for starting, monitoring, and stopping help reduce risks and improve outcomes.

Starting, Titrating, And Monitoring

Begin with 25 mg at bedtime for adults with OCD and increase slowly by about 25 mg increments as tolerated.

Acute titration commonly occurs over 2–3 weeks with regular review of side effects and efficacy.

Baseline assessments should include a medication list, cardiac history, ECG if indicated, renal and hepatic assessment if necessary, and pregnancy status.

Long-Term Management And Stopping

For maintenance, regularly review benefit versus side effects and aim for the lowest effective dose.

When discontinuing, taper slowly under supervision to minimize withdrawal and relapse risk.

Store medication at 20–25°C (68–77°F) in original packaging and keep an emergency card listing contraindications and prescriber contact information.

• Monitoring & Taper Template
• Baseline: medication review, ECG if cardiac risk, basic labs as indicated.
• Titration Phase: clinic follow-up every 1–2 weeks for side effects and dose adjustment.
• Maintenance: review every 3 months or as clinically indicated.

Delivery Across United States